insights_auto
Why is CYTK down 2.15%?
Dive Deeperchevron_right
CYTK:NASDAQ
Cytokinetics, Inc.
$61.35
arrow_downward
-2.15%(-1.35) 1D
$61.35
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$62.20
High
$62.52
Low
$60.68
Mkt. cap
8.92B
Avg. vol.
2.09M
Volume
0.00
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
Open
$62.20
High
$62.52
Low
$60.68
Mkt. cap
8.92B
Avg. vol.
2.09M
Volume
0.00
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
AD HOC NEWS
·
18 hours ago
Cytokinetics announces four HFSA presentations: 18 analysts rate Cytokinetics stock Buy
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com